Carrick Therapeutics

Developer of oncology therapies targeting molecular pathways in resistant cancers

placeOxford, England, United Kingdom calendar_todayFounded 2015 groups23 employees language carricktherapeutics.com

Registered entities

Social engagement

Social engagement: 3.3K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Arch Venture Partners, Rosetta Capital, Google Ventures, Evotec.

Investor typeCountShare
Venture capital969%
Other / undisclosed431%
Coming soon